SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (5517)3/25/1998 11:22:00 AM
From: John Brickman  Read Replies (1) | Respond to of 18691
 
Hank: You're right; for some reason I was reading that as FDA approval. This market has me shell shocked right now so its probably a good time to back off some anyway.

JB



To: Hank who wrote (5517)3/25/1998 2:33:00 PM
From: BDR  Read Replies (2) | Respond to of 18691
 
<<A patent is not an FDA
approval to sell Vasomax.>>

Very true. They have the patent for the route of absorption of phentolamine through the buccal mucosa and how much revenue or profits is that providing? As I see it they now have a patent on a placebo.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News